How to Use Your Spiriva Respimat Inhaler Step by Step

Spiriva Respimat is a slow-mist inhaler that delivers tiotropium bromide in a fine, long-lasting spray, and using it correctly involves a specific sequence: turning the base to load a dose, opening the cap, exhaling fully, then pressing the dose-release button while breathing in slowly. The technique differs from a standard puffer, and the details matter more than you might expect. Research shows that roughly six out of ten people using soft mist inhalers make at least one error that can reduce how much medicine reaches their lungs.

Setting Up a New Respimat for the First Time

Before you take your first dose, you need to insert the drug cartridge and prime the device. Start with the cap closed. Press the safety catch on the side of the inhaler and pull off the clear base. Take the narrow end of the cartridge and push it firmly into the inhaler until you hear a click. Replace the base. The cartridge sits inside the device permanently; you do not remove it between doses.

Priming clears the internal mechanism and ensures the spray is consistent. To prime, hold the inhaler upright with the cap closed. Turn the clear base in the direction of the arrows (about a half-turn) until you hear a click. Flip the cap open. Point the mouthpiece away from your face and press the dose-release button. Close the cap and repeat this turn-open-spray sequence a total of three times. You will see three small clouds of mist, which means the inhaler is ready. These priming sprays are wasted doses, but they are necessary for proper function.

If you go more than three days without using the Respimat, fire one spray into the air before your next dose. If you go more than 21 days without use, repeat the full three-spray priming sequence as if it were a brand-new device.

Step-by-Step Inhalation Technique

Each treatment session with Spiriva Respimat typically involves two puffs. The standard prescribed dose for adults with COPD is two inhalations of 2.5 micrograms once daily (delivering a total of 5 micrograms), and the same applies for asthma when prescribed as add-on therapy. Here is the full process for each puff:

Load the dose: With the cap closed and the inhaler held upright, turn the clear base in the direction of the arrows until it clicks. This loads one metered dose into the chamber.
Open the cap: Flip the green or clear cap fully open. The mouthpiece is now exposed.
Exhale completely: Breathe out slowly and fully, away from the mouthpiece. Do not breathe into the device.
Seal your lips: Close your lips tightly around the mouthpiece. Keep the inhaler pointed toward the back of your throat, holding it horizontally or slightly tilted upward.
Press and breathe: While breathing in slowly and deeply through your mouth, press the dose-release button with your thumb. Continue inhaling as steadily as you can after the spray fires.
Hold your breath: Remove the inhaler from your mouth and hold your breath for up to ten seconds, or as long as is comfortable.
Close the cap: Close the cap after each puff. Repeat the entire sequence for your second puff.

The key word in that sequence is “slowly.” Unlike a dry powder inhaler, which requires a sharp, forceful breath, the Respimat works best with a gentle, steady inhalation. The device generates its own fine mist using a spring mechanism, so you do not need to inhale hard to draw the drug out. A slow breath lets the mist travel deeper into your airways rather than slamming into the back of your throat.

Why Slow Inhalation Matters With This Device

The Respimat produces an aerosol cloud that moves slowly and lasts longer than the spray from a traditional pressurized metered-dose inhaler. This is by design. Studies using lung-imaging techniques have found that the Respimat delivers a higher fraction of its dose to the lungs compared with pressurized inhalers, even among people with poor technique. In one study, untrained patients deposited about 37% of the delivered dose in their lungs using the Respimat, compared with about 21% from a pressurized inhaler. Trained patients did even better, reaching roughly 53% lung deposition with the Respimat.¹

The practical takeaway is that the Respimat is more forgiving than a standard puffer, but it still rewards good technique. Modeling studies have shown that at least half the nominal dose reaches the lungs regardless of the breathing pattern, and more than half of what reaches the lungs deposits in the small peripheral airways, which is where the drug needs to act.² The slow-moving mist and longer spray duration also make it easier to coordinate pressing the button with breathing in, which is one of the trickiest parts of using any inhaler.³

The Most Common Mistakes and How to Avoid Them

A global review of studies on soft mist inhaler use found that about 59% of patients made at least one error.⁴ That number is striking given that the Respimat is considered easier to use than many alternatives. The five most frequent errors, ranked by how often they occurred across studies, paint a clear picture of where things go wrong:

Not exhaling fully before inhaling: Nearly half of patients skipped a complete exhale before breathing in. Without emptying your lungs first, there is less room for the medicated mist, and it will not penetrate as deeply.
Not holding breath afterward: About 31% of patients failed to hold their breath for up to ten seconds. This settling time lets the drug particles deposit on airway surfaces instead of being immediately exhaled.
Breathing in too fast: Around 28% did not take a slow, deep breath while pressing the button. Rushing the inhalation causes more of the drug to impact the mouth and throat rather than traveling to the lungs.
Not holding the inhaler upright: About 23% held the device at an angle while loading or inhaling. The Respimat needs to be roughly vertical when you turn the base so the internal mechanism loads properly.
Not turning the base until it clicks: About 18% failed to complete the half-turn that loads the dose, meaning they pressed the button without a full dose in the chamber.

Most of these errors are easy to fix once you know to watch for them. The exhale-before-inhaling step is the one people skip most casually, probably because it feels unnecessary. It is not. And the “hold your breath” step often gets cut short simply because people forget or feel impatient. Setting a mental count of seven to ten seconds helps.

What Spiriva Respimat Treats

Spiriva Respimat is approved for two major conditions: chronic obstructive pulmonary disease and asthma. The active drug, tiotropium, is a long-acting bronchodilator that works by relaxing the muscles around your airways, keeping them open for about 24 hours per dose. It is a maintenance medication, meaning you use it every day on a schedule. It is not a rescue inhaler and will not help during an acute asthma attack or a sudden episode of severe breathlessness.

In COPD, tiotropium Respimat at 5 micrograms once daily has been shown to improve lung function, reduce breathlessness, improve quality of life, and cut the rate of flare-ups. Large trials found that compared with placebo, tiotropium reduced the risk of exacerbations by about 25 to 31%.⁵ These benefits were consistent whether researchers looked at lung-function measurements, symptom scores, or how often people ended up needing extra treatment for a flare-up.

For asthma, Spiriva Respimat is used as an add-on when inhaled corticosteroids alone, or inhaled corticosteroids plus a long-acting beta-agonist, are not controlling symptoms well enough. Clinical trials showed that adding tiotropium Respimat improved lung function and extended the time before the next exacerbation in people whose asthma remained poorly controlled on high-dose inhaled steroids and a long-acting beta-agonist.⁶ In patients with moderate asthma on medium-dose inhaled steroids, the 5-microgram dose showed the largest improvements in lung function.⁷ These benefits appeared regardless of patient age, sex, or other baseline characteristics.⁸

Side Effects to Watch For

Tiotropium Respimat is generally well tolerated. The most commonly reported side effects are related to its anticholinergic action: dry mouth is the one people notice most. Other possible effects include sore throat, constipation, and urinary retention, though these are less frequent. If you notice blurred vision or eye pain after a dose accidentally sprays into your eyes, contact your doctor, as tiotropium can temporarily affect the pupils.

Earlier safety concerns about a possible increased risk of cardiovascular events with the Respimat formulation were resolved by a large head-to-head trial comparing Respimat with the older HandiHaler dry-powder device. That trial found no significant difference in mortality, cardiovascular death, or major cardiovascular events between the two delivery systems.⁹ The same trial confirmed that the Respimat’s 5-microgram dose was equivalent in efficacy to the HandiHaler’s 18-microgram dose, which makes sense because the Respimat delivers a larger share of each dose to the lungs and therefore needs a smaller total amount of drug.¹⁰

Respimat Versus the HandiHaler

If you have used the Spiriva HandiHaler before, the Respimat is a different experience. The HandiHaler is a dry powder device that uses individual capsules punctured before each inhalation and requires a strong inspiratory effort. The Respimat uses a liquid cartridge and generates its own aerosol mechanically, so it does not depend on how hard you breathe in. This makes the Respimat a better fit for people who have difficulty generating a fast inhalation, including some elderly patients and those with severe airflow obstruction.

Head-to-head comparisons across multiple trials have confirmed that 5 micrograms via Respimat produces the same bronchodilator effect as 18 micrograms via HandiHaler.¹¹ A study in Japanese patients with COPD confirmed this equivalence, finding nearly identical lung-function responses and similar rates of adverse events between the two devices.¹² Lower Respimat doses of 1.25 or 2.5 micrograms did not match the HandiHaler, so the 5-microgram dose is the standard for COPD.¹³

Use in Children and Older Adults

Spiriva Respimat is approved for asthma in children as young as six in some countries, but the device does present handling challenges for younger users. A study examining whether children under five could use the Respimat found that those under three struggled to enclose the mouthpiece properly, while children aged three to four had difficulty with the same step (about 62% could not do it). Coordinating the button press with inhalation was the hardest part for children aged four to five, with roughly 75% unable to manage it even with parental help.¹⁴ For very young children who need tiotropium, a face mask and spacer attachment may be required, and this is something your pediatrician or respiratory therapist can demonstrate.

Older adults face a different set of challenges. The base requires a certain amount of grip strength to twist, and arthritis or hand weakness can make the half-turn loading step difficult. If you struggle to turn the base, pressing the inhaler against a table or countertop while turning can provide extra leverage. Some pharmacies also sell grip aids designed for the Respimat. The good news is that the slow-moving mist is particularly suited to older users who may not be able to coordinate the fast “press and gasp” timing that standard pressurized inhalers demand.

Cleaning and Cartridge Replacement

The Respimat does not need daily cleaning, but keeping the mouthpiece free of buildup helps ensure consistent spray quality. About once a week, wipe the mouthpiece, including the metal portion inside the tip, with a damp cloth or tissue. Do not submerge the inhaler in water or put it through a dishwasher. If the spray pattern seems uneven or weak, check that the air vent on the mouthpiece is not blocked.

Each cartridge contains a set number of doses, typically 60 puffs for the 30-day supply (two puffs per day). A dose indicator on the side of the inhaler counts down so you know when to start a new cartridge. When the indicator reaches zero, the inhaler locks. With the original disposable version, you discard the entire device and start fresh. With the newer reusable Respimat, you keep the same inhaler body and insert a new cartridge, then re-prime with three sprays before your next dose.

The Reusable Version and Environmental Impact

Boehringer Ingelheim introduced a reusable Respimat that accepts refill cartridges, and its environmental footprint is considerably smaller than standard pressurized inhalers. Pressurized metered-dose inhalers rely on hydrofluoroalkane (HFA) propellant gases, which are potent greenhouse gases. The Respimat uses a spring mechanism instead of a propellant, so its carbon footprint per dose is a fraction of a standard puffer’s. One lifecycle analysis found that the carbon dioxide equivalent per kilogram for the disposable Spiriva Respimat was 0.78, compared with roughly 14.6 to 16.5 for HFA pressurized inhalers. Using the reusable Respimat with refill cartridges over six months further reduced the footprint by about 71% compared with using a fresh disposable device each month.¹⁵

This does not mean you should switch inhalers purely for environmental reasons, but if your doctor offers you a choice between a pressurized inhaler and a Respimat for the same medication, the Respimat is the greener option by a wide margin. The reusable model also saves waste from the device itself, since you are not throwing away the plastic body every month.

Troubleshooting Common Problems

A few issues come up regularly with the Respimat, and most have simple fixes:

No spray when you press the button: You probably did not turn the base until it clicked. Close the cap, turn the base fully (you should hear and feel a definite click), and try again.
Spray fires before you start breathing in: This is a coordination issue. Try a “ready, set, go” approach: exhale fully, position the mouthpiece, then begin a slow inhalation and press the button about half a second into the breath. The Respimat’s cloud lasts longer than a standard puffer’s burst, so you have a wider window to catch it.
You feel very little mist: Make sure you are not breathing in too forcefully. A fast, sharp breath disperses the mist and sends more of it to your throat. Slow down your inhalation until it feels almost unnaturally gentle.
The base is hard to turn: Grip the body of the inhaler firmly in one hand and the clear base in the other. Some people find it easier to keep the body stationary and rotate the base, while others prefer to hold the base and rotate the body. If arthritis makes this impossible, ask your pharmacist about a grip-assist accessory.
You are not sure if you got a full dose: Do not fire a third spray to “make up” for a missed one. Take your two prescribed puffs each day. If you are consistently uncertain whether you are inhaling correctly, ask your doctor or pharmacist to watch you use the device and correct your technique in real time. Even a single in-person demonstration session makes a measurable difference in error rates.

When to Take Your Dose

Spiriva Respimat is a once-daily medication, and consistency in timing matters more than the specific hour you choose. Most people find it easiest to use the inhaler at the same time each morning, since tiotropium provides bronchodilation for about 24 hours and a morning dose helps keep airways open throughout the day and night. If you miss a dose, take it as soon as you remember, but if it is nearly time for your next dose, skip the missed one and resume your usual schedule. Do not double up.

If you are also using a rescue inhaler (such as albuterol) and a steroid inhaler, the general recommendation is to use the Spiriva Respimat first, wait a few minutes, then use any other inhalers. The bronchodilating effect of tiotropium can open the airways enough to improve the delivery of subsequent medications. Your prescriber may give you a specific order based on your combination of medications, so follow their guidance if it differs.